CNS PHARMACEUTICALS ($CNSP) Releases Q2 2026 Earnings
By: Quiver EarningsTracker
Posted: an hour ago / Aug. 12, 2026 12:31 p.m. UTC
CNS PHARMACEUTICALS ($CNSP) posted quarterly earnings results for Q2 2026 on Wednesday, August 12th. The company reported earnings of -$0.38 per share, missing estimates of -$0.24 by $0.14. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative’s $CNSP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CNS PHARMACEUTICALS Insider Trading Activity
CNS PHARMACEUTICALS insiders have traded $CNSP stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CNSP stock by insiders over the last 6 months:
- FAITH L. CHARLES purchased 7,100 shares for an estimated $34,001
To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CNS PHARMACEUTICALS Hedge Fund Activity
We have seen 3 institutional investors add shares of CNS PHARMACEUTICALS stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GEODE CAPITAL MANAGEMENT, LLC added 23,189 shares (+inf%) to their portfolio in Q1 2026, for an estimated $55,421
- DRW SECURITIES, LLC removed 15,429 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $36,875
- STONEPINE CAPITAL MANAGEMENT, LLC added 12,173 shares (+24.9%) to their portfolio in Q1 2026, for an estimated $29,093
- TOWER RESEARCH CAPITAL LLC (TRC) removed 511 shares (-39.0%) from their portfolio in Q2 2026, for an estimated $2,442
- UBS GROUP AG added 118 shares (+19.3%) to their portfolio in Q1 2026, for an estimated $282
- SOUND INCOME STRATEGIES, LLC removed 16 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $76
- BANK OF AMERICA CORP /DE/ removed 4 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
